Global and Japan Tauopathies Treatment Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tauopathies Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 SEL-141
1.2.3 RDC-5
1.2.4 YM-08
1.2.5 Thiamet-G
1.2.6 Others
1.3 Market by Application
1.3.1 Global Tauopathies Treatment Market Share by Application: 2020 VS 2026
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Tauopathies Treatment Market Perspective (2015-2026)
2.2 Global Tauopathies Treatment Growth Trends by Regions
2.2.1 Tauopathies Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Tauopathies Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Tauopathies Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tauopathies Treatment Players by Market Size
3.1.1 Global Top Tauopathies Treatment Players by Revenue (2015-2020)
3.1.2 Global Tauopathies Treatment Revenue Market Share by Players (2015-2020)
3.2 Global Tauopathies Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Tauopathies Treatment Revenue
3.4 Global Tauopathies Treatment Market Concentration Ratio
3.4.1 Global Tauopathies Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tauopathies Treatment Revenue in 2019
3.5 Key Players Tauopathies Treatment Area Served
3.6 Key Players Tauopathies Treatment Product Solution and Service
3.7 Date of Enter into Tauopathies Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tauopathies Treatment Breakdown Data by Type (2015-2026)
4.1 Global Tauopathies Treatment Historic Market Size by Type (2015-2020)
4.2 Global Tauopathies Treatment Forecasted Market Size by Type (2021-2026)
5 Tauopathies Treatment Breakdown Data by Application (2015-2026)
5.1 Global Tauopathies Treatment Historic Market Size by Application (2015-2020)
5.2 Global Tauopathies Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Tauopathies Treatment Market Size (2015-2026)
6.2 North America Tauopathies Treatment Market Size by Type (2015-2020)
6.3 North America Tauopathies Treatment Market Size by Application (2015-2020)
6.4 North America Tauopathies Treatment Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Tauopathies Treatment Market Size (2015-2026)
7.2 Europe Tauopathies Treatment Market Size by Type (2015-2020)
7.3 Europe Tauopathies Treatment Market Size by Application (2015-2020)
7.4 Europe Tauopathies Treatment Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Tauopathies Treatment Market Size (2015-2026)
8.2 China Tauopathies Treatment Market Size by Type (2015-2020)
8.3 China Tauopathies Treatment Market Size by Application (2015-2020)
8.4 China Tauopathies Treatment Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Tauopathies Treatment Market Size (2015-2026)
9.2 Japan Tauopathies Treatment Market Size by Type (2015-2020)
9.3 Japan Tauopathies Treatment Market Size by Application (2015-2020)
9.4 Japan Tauopathies Treatment Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Tauopathies Treatment Market Size (2015-2026)
10.2 Southeast Asia Tauopathies Treatment Market Size by Type (2015-2020)
10.3 Southeast Asia Tauopathies Treatment Market Size by Application (2015-2020)
10.4 Southeast Asia Tauopathies Treatment Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Bristol-Myers Squibb Company
11.1.1 Bristol-Myers Squibb Company Company Details
11.1.2 Bristol-Myers Squibb Company Business Overview
11.1.3 Bristol-Myers Squibb Company Tauopathies Treatment Introduction
11.1.4 Bristol-Myers Squibb Company Revenue in Tauopathies Treatment Business (2015-2020))
11.1.5 Bristol-Myers Squibb Company Recent Development
11.2 Selvita S.A
11.2.1 Selvita S.A Company Details
11.2.2 Selvita S.A Business Overview
11.2.3 Selvita S.A Tauopathies Treatment Introduction
11.2.4 Selvita S.A Revenue in Tauopathies Treatment Business (2015-2020)
11.2.5 Selvita S.A Recent Development
11.3 SK Biopharmaceuticals Co., Ltd.
11.3.1 SK Biopharmaceuticals Co., Ltd. Company Details
11.3.2 SK Biopharmaceuticals Co., Ltd. Business Overview
11.3.3 SK Biopharmaceuticals Co., Ltd. Tauopathies Treatment Introduction
11.3.4 SK Biopharmaceuticals Co., Ltd. Revenue in Tauopathies Treatment Business (2015-2020)
11.3.5 SK Biopharmaceuticals Co., Ltd. Recent Development
11.4 Chronos Therapeutics Limited
11.4.1 Chronos Therapeutics Limited Company Details
11.4.2 Chronos Therapeutics Limited Business Overview
11.4.3 Chronos Therapeutics Limited Tauopathies Treatment Introduction
11.4.4 Chronos Therapeutics Limited Revenue in Tauopathies Treatment Business (2015-2020)
11.4.5 Chronos Therapeutics Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Tauopathies Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of SEL-141
Table 4. Key Players of RDC-5
Table 5. Key Players of YM-08
Table 6. Key Players of Thiamet-G
Table 7. Key Players of Others
Table 8. Global Tauopathies Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Tauopathies Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Tauopathies Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Tauopathies Treatment Market Share by Regions (2015-2020)
Table 12. Global Tauopathies Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Tauopathies Treatment Market Share by Regions (2021-2026)
Table 14. Tauopathies Treatment Market Market Trends
Table 15. Tauopathies Treatment Market Drivers
Table 16. Tauopathies Treatment Market Challenges
Table 17. Tauopathies Treatment Market Restraints
Table 18. Global Tauopathies Treatment Revenue by Players (2015-2020) (US$ Million)
Table 19. Global Tauopathies Treatment Market Share by Players (2015-2020)
Table 20. Global Top Tauopathies Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tauopathies Treatment as of 2019)
Table 21. Global Tauopathies Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Tauopathies Treatment Product Solution and Service
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Tauopathies Treatment Market Size by Type (2015-2020) (US$ Million)
Table 26. Global Tauopathies Treatment Market Size Share by Type (2015-2020)
Table 27. Global Tauopathies Treatment Revenue Market Share by Type (2021-2026)
Table 28. Global Tauopathies Treatment Market Size Share by Application (2015-2020)
Table 29. Global Tauopathies Treatment Market Size by Application (2015-2020) (US$ Million)
Table 30. Global Tauopathies Treatment Market Size Share by Application (2021-2026)
Table 31. North America Tauopathies Treatment Market Size by Type (2015-2020) (US$ Million)
Table 32. North America Tauopathies Treatment Market Share by Type (2015-2020)
Table 33. North America Tauopathies Treatment Market Size by Application (2015-2020) (US$ Million)
Table 34. North America Tauopathies Treatment Market Share by Application (2015-2020)
Table 35. North America Tauopathies Treatment Market Size by Country (US$ Million) (2015-2020)
Table 36. North America Tauopathies Treatment Market Share by Country (2015-2020)
Table 37. Europe Tauopathies Treatment Market Size by Type (2015-2020) (US$ Million)
Table 38. Europe Tauopathies Treatment Market Share by Type (2015-2020)
Table 39. Europe Tauopathies Treatment Market Size by Application (2015-2020) (US$ Million)
Table 40. Europe Tauopathies Treatment Market Share by Application (2015-2020)
Table 41. Europe Tauopathies Treatment Market Size by Country (US$ Million) (2015-2020)
Table 42. Europe Tauopathies Treatment Market Share by Country (2015-2020)
Table 43. China Tauopathies Treatment Market Size by Type (2015-2020) (US$ Million)
Table 44. China Tauopathies Treatment Market Share by Type (2015-2020)
Table 45. China Tauopathies Treatment Market Size by Application (2015-2020) (US$ Million)
Table 46. China Tauopathies Treatment Market Share by Application (2015-2020)
Table 47. China Tauopathies Treatment Market Size by Region (US$ Million) (2015-2020)
Table 48. China Tauopathies Treatment Market Share by Region (2015-2020)
Table 49. Japan Tauopathies Treatment Market Size by Type (2015-2020) (US$ Million)
Table 50. Japan Tauopathies Treatment Market Share by Type (2015-2020)
Table 51. Japan Tauopathies Treatment Market Size by Application (2015-2020) (US$ Million)
Table 52. Japan Tauopathies Treatment Market Share by Application (2015-2020)
Table 53. Japan Tauopathies Treatment Market Size by Country (US$ Million) (2015-2020)
Table 54. Japan Tauopathies Treatment Market Share by Country (2015-2020)
Table 55. Southeast Asia Tauopathies Treatment Market Size by Type (2015-2020) (US$ Million)
Table 56. Southeast Asia Tauopathies Treatment Market Share by Type (2015-2020)
Table 57. Southeast Asia Tauopathies Treatment Market Size by Application (2015-2020) (US$ Million)
Table 58. Southeast Asia Tauopathies Treatment Market Share by Application (2015-2020)
Table 59. Southeast Asia Tauopathies Treatment Market Size by Country (US$ Million) (2015-2020)
Table 60. Southeast Asia Tauopathies Treatment Market Share by Country (2015-2020)
Table 61. Bristol-Myers Squibb Company Company Details
Table 62. Bristol-Myers Squibb Company Business Overview
Table 63. Bristol-Myers Squibb Company Product
Table 64. Bristol-Myers Squibb Company Revenue in Tauopathies Treatment Business (2015-2020) (US$ Million)
Table 65. Bristol-Myers Squibb Company Recent Development
Table 66. Selvita S.A Company Details
Table 67. Selvita S.A Business Overview
Table 68. Selvita S.A Product
Table 69. Selvita S.A Revenue in Tauopathies Treatment Business (2015-2020) (US$ Million)
Table 70. Selvita S.A Recent Development
Table 71. SK Biopharmaceuticals Co., Ltd. Company Details
Table 72. SK Biopharmaceuticals Co., Ltd. Business Overview
Table 73. SK Biopharmaceuticals Co., Ltd. Product
Table 74. SK Biopharmaceuticals Co., Ltd. Revenue in Tauopathies Treatment Business (2015-2020) (US$ Million)
Table 75. SK Biopharmaceuticals Co., Ltd. Recent Development
Table 76. Chronos Therapeutics Limited Company Details
Table 77. Chronos Therapeutics Limited Business Overview
Table 78. Chronos Therapeutics Limited Product
Table 79. Chronos Therapeutics Limited Revenue in Tauopathies Treatment Business (2015-2020) (US$ Million)
Table 80. Chronos Therapeutics Limited Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Tauopathies Treatment Market Share by Type: 2020 VS 2026
Figure 2. SEL-141 Features
Figure 3. RDC-5 Features
Figure 4. YM-08 Features
Figure 5. Thiamet-G Features
Figure 6. Others Features
Figure 7. Global Tauopathies Treatment Market Share by Application: 2020 VS 2026
Figure 8. Clinic Case Studies
Figure 9. Hospital Case Studies
Figure 10. Others Case Studies
Figure 11. Tauopathies Treatment Report Years Considered
Figure 12. Global Tauopathies Treatment Market Size (US$ Million), YoY Growth 2015-2026
Figure 13. Global Tauopathies Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Tauopathies Treatment Market Share by Regions (2021-2026)
Figure 15. Global Tauopathies Treatment Market Share by Players in 2019
Figure 16. Global Top Tauopathies Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tauopathies Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Tauopathies Treatment Revenue in 2019
Figure 18. North America Tauopathies Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. United States Tauopathies Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Canada Tauopathies Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Europe Tauopathies Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Germany Tauopathies Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. France Tauopathies Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. U.K. Tauopathies Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Italy Tauopathies Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Russia Tauopathies Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Nordic Tauopathies Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Rest of Europe Tauopathies Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Asia-Pacific Tauopathies Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. China Tauopathies Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Japan Tauopathies Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. South Korea Tauopathies Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Southeast Asia Tauopathies Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. India Tauopathies Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Australia Tauopathies Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Rest of Asia-Pacific Tauopathies Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Latin America Tauopathies Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Mexico Tauopathies Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Brazil Tauopathies Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Middle East & Africa Tauopathies Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Turkey Tauopathies Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Saudi Arabia Tauopathies Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. UAE Tauopathies Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Rest of Middle East & Africa Tauopathies Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Bristol-Myers Squibb Company Revenue Growth Rate in Tauopathies Treatment Business (2015-2020)
Figure 46. Selvita S.A Revenue Growth Rate in Tauopathies Treatment Business (2015-2020)
Figure 47. SK Biopharmaceuticals Co., Ltd. Revenue Growth Rate in Tauopathies Treatment Business (2015-2020)
Figure 48. Chronos Therapeutics Limited Revenue Growth Rate in Tauopathies Treatment Business (2015-2020)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed